Edition:
United States

Cocrystal Pharma Inc (COCP.OQ)

COCP.OQ on NASDAQ Stock Exchange Capital Market

2.02USD
21 May 2018
Change (% chg)

-- (--)
Prev Close
$2.02
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$6.43
52-wk Low
$1.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.064
FY 2017 Dec '17 0.00 0.212
Sep '17 0.00 -0.093
Jun '17 0.00 -0.041
Mar '17 0.00 -0.107
FY 2016 Dec '16 0.00 -2.762
Sep '16 0.00 -0.080
Jun '16 0.00 -0.137
Mar '16 0.00 -0.173
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 140.61 28.56 32.59
P/E High - Last 5 Yrs. -- 41.38 47.07
P/E Low - Last 5 Yrs. -- 23.34 24.59
Beta 1.59 0.80 0.79
Price to Sales (TTM) -- 4.18 9.01
Price to Book (MRQ) 0.46 3.50 4.24
Price to Tangible Book (MRQ) -- 4.37 5.79
Price to Cash Flow (TTM) 118.21 19.51 21.78
% Owned Institutions 0.73 1.29 2.43

Dividends

  Company industry sector
Dividend Yield -- 1.79 1.66
Dividend Yield - 5 Year Avg -- 0.79 0.80
Dividend 5 Year Growth Rate -- 2.73 4.15
Payout Ratio(TTM) 0.00 16.91 17.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.99 5.10
Sales (TTM) vs TTM 1 Yr. Ago -- 10.28 12.65
Sales - 5 Yr. Growth Rate -- 7.42 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 40.51 37.70 33.25
EPS (TTM) vs TTM 1 Yr. Ago 100.45 -- --
EPS - 5 Yr. Growth Rate -- 7.07 8.54
Capital Spending - 5 Yr. Growth Rate -23.45 8.26 8.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.50
Current Ratio (MRQ) 1.09 3.58 3.56
LT Debt to Equity (MRQ) 1.96 10.41 12.86
Total Debt to Equity (MRQ) 1.96 12.80 15.83
Interest Coverage (TTM) -- 40.27 35.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.48 54.64
Gross Margin - 5 Yr. Avg. -- 52.71 52.74
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -203,425.30 18.50 15.84
Operating Margin (TTM) -- 12.71 -2.34
Operating Margin - 5 Yr. Avg. -208,455.20 14.23 11.09
Pre-Tax Margin (TTM) -- 13.00 -0.23
Pre-Tax Margin - 5 Yr. Avg. -208,240.20 14.51 11.29
Net Profit Margin (TTM) -- 9.41 -3.64
Net Profit Margin - 5 Yr. Avg. -148,959.80 10.79 7.58
Effective Tax Rate (TTM) -- 22.43 31.25
Effective Tax Rate - 5 Yr. Avg. -- 23.90 24.61

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 831,280,368 721,262,098
Net Income/Employee (TTM) 38,200 96,677,550 83,813,821
Receivable Turnover (TTM) -- 5.53 5.67
Inventory Turnover (TTM) -- 2.50 3.55
Asset Turnover (TTM) 0.00 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 0.31 10.44 9.98
Return on Assets - 5 Yr. Avg. -19.22 11.65 11.07
Return on Investment (TTM) 0.32 13.05 12.60
Return on Investment - 5 Yr. Avg. -19.94 15.07 14.34
Return on Equity (TTM) 0.37 14.79 14.49
Return on Equity - 5 Yr. Avg. -40.67 16.32 15.71
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 99.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cocrystal Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.73%
# of Holders: 15
Total Shares Held: 209,270
3 Mo. Net Change: 205,271
# New Positions: 13
# Closed Positions: 1
# Increased Positions: 14
# Reduced Positions: 2
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.